fda warning bpc-157 not approved safety concerns panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers Stuffy nose? Reach for phenylephrine!

Stuffy nose? Reach for phenylephrine! Well, not anymore. Last week, the FDA announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in OTC drug products The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access. MORE BELOW Federal health advisers are meeting to review a group of controversial chemicals called peptides, which have become a growing wellness trend. FULL STORY US Panel Backs Trendy Peptides Despite Safety Concerns Barron's The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link FDA panel narrowly backs unapproved peptide drugs NBC4 Washington

SKU: 21268850541 · From ldesquadrias.com.br